Clinical Development ProgressAlto Neuroscience's progress with the ALTO-101 transdermal administration supports the drug's potential to improve CIAS symptoms with a better AE profile.

Financial StabilityCompany has a cash runway into 2027, indicating strong financial stability.

Innovative Research And DevelopmentAlto’s Precision Platform identifies therapeutics with higher probabilities of clinical success by using brain-based biomarkers.

Bears Say

EarningsManagement reported a significant earnings miss with an EPS of ($0.76), far below the estimated ($0.47)/($0.46), due to rising operating expenses from ongoing Phase 2b trials.

Financial HealthANRO reported a substantial net loss of $13.4MM, highlighting potential concerns over the company's financial stability.

Research And Development CostsANRO's net loss of $36.3MM underscores the heavy financial burden of its current investment in research and development, which could affect its short-term financial performance.

---

Financials

Annual

Income Statement >

Ownership Overview

24.97% Insiders

4.09% Mutual Funds

25.29% Other Institutional Investors

45.65% Public Companies and

Individual Investors

Detailed Ownership Overview >

Risk Analysis

Main Risk Category

Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Detailed Risk Analysis >

ANRO FAQ

What was Alto Neuroscience, Inc.’s price range in the past 12 months?

Alto Neuroscience, Inc. lowest stock price was $12.17 and its highest was $24.00 in the past 12 months.

What is Alto Neuroscience, Inc.’s market cap?

Currently, no data Available

When is Alto Neuroscience, Inc.’s upcoming earnings report date?

Alto Neuroscience, Inc.’s upcoming earnings report date is May 14, 2024 which is 6 days ago.

How were Alto Neuroscience, Inc.’s earnings last quarter?

Alto Neuroscience, Inc. released its earnings results on Mar 21, 2024. The company reported -$2.8 earnings per share for the quarter, missing the consensus estimate of -$0.835 by -$1.965.

Is Alto Neuroscience, Inc. overvalued?

According to Wall Street analysts Alto Neuroscience, Inc.’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Alto Neuroscience, Inc. pay dividends?

Alto Neuroscience, Inc. does not currently pay dividends.

What is Alto Neuroscience, Inc.’s EPS estimate?

Alto Neuroscience, Inc.’s EPS estimate is -$0.46.

How many shares outstanding does Alto Neuroscience, Inc. have?

Alto Neuroscience, Inc. has 26,883,990 shares outstanding.

What happened to Alto Neuroscience, Inc.’s price movement after its last earnings report?

Alto Neuroscience, Inc. reported an EPS of -$2.8 in its last earnings report, missing expectations of -$0.835. Following the earnings report the stock price went down -2.26%.

Which hedge fund is a major shareholder of Alto Neuroscience, Inc.?

Among the largest hedge funds holding Alto Neuroscience, Inc.’s share is RA Capital Management. It holds Alto Neuroscience, Inc.’s shares valued at 21M.

---

Alto Neuroscience, Inc. Stock Smart Score

Not Ranked

Company Description

Alto Neuroscience, Inc.

Alto Neuroscience is a clinical-stage biopharmaceutical company with a mission to redefine neuropsychiatric care by leveraging neurobiology to develop personalized and highly effective treatment options. Through our AI-enabled biomarker platform, we combine rich sources of information on patients¿ brain activity and behavior to better identify which patients are more likely to respond to our novel product candidates.

---

ANRO Stock 12 Month Forecast

Average Price Target

$32.33

▲(159.26% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"plus_tr_sans","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"13":"$13","34":"$34","18.25":"$18.25","23.5":"$23.5","28.75":"$28.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":33,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n  <span style=\"color:#199ca5\">$33.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":32.33,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n  <span style=\"color:#828080\">$32.33</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":32,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n  <span style=\"color:#912767\">$32.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[13,18.25,23.5,28.75,34],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Sep<br/>2023","6":"Dec<br/>2023","9":"Mar<br/>2024","12":"May<br/>2024","25":"May<br/>2025"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,14.22,15.664615384615384,17.10923076923077,18.553846153846155,19.99846153846154,21.443076923076923,22.88769230769231,24.332307692307694,25.776923076923076,27.221538461538465,28.666153846153847,30.11076923076923,31.555384615384618,{"y":33,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,14.22,15.613076923076925,17.006153846153847,18.39923076923077,19.792307692307695,21.185384615384617,22.57846153846154,23.971538461538465,25.364615384615384,26.75769230769231,28.15076923076923,29.543846153846154,30.93692307692308,{"y":32.33,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,14.22,15.587692307692308,16.955384615384617,18.323076923076925,19.69076923076923,21.05846153846154,22.426153846153845,23.793846153846154,25.161538461538463,26.52923076923077,27.89692307692308,29.264615384615386,30.63230769230769,{"y":32,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":21.8,"date":1685577600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":21.8,"date":1688169600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":21.8,"date":1690848000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":21.8,"date":1693526400000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":21.8,"date":1696118400000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":21.8,"date":1698796800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":21.8,"date":1701388800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":21.8,"date":1704067200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":21.8,"date":1706745600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":14.88,"date":1709251200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":14.88,"date":1709251200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":14.52,"date":1712275200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":14.22,"date":1714694400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >

Technical Analysis

Best Analysts Covering ANRO

1 Year

Brian SkorneyRobert W. Baird

1 Year Success Rate

0/3 ratings generated profit

1 Year Average Return

-12.33%

reiterated a buy rating 6 days ago

Copying Brian Skorney's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -12.33% per trade.

Best Analyst Covering >

Popular Stocks

---

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing

Alto Neuroscience, Inc. (ANRO) Stock Price & Analysis

ANRO Stock Chart & Stats

Alto Neuroscience, Inc. News

Bulls Say, Bears Say

Financials

Ownership Overview

Risk Analysis

ANRO FAQ

Alto Neuroscience, Inc. Stock Smart Score

Analyst Consensus

Insider Transactions

News Sentiment

Company Description

Alto Neuroscience, Inc.

ANRO Stock 12 Month Forecast

Average Price Target

Technical Analysis

Best Analysts Covering ANRO

Get More with TipRanks Premium